60 Degrees Pharmaceuticals enrolls first patient in tafenoquine babesiosis trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. ACN
2. NVDA
3. SPCX
4. MU
5. LCO
6. KR
7. APGE
8. MSTR
9. ABBV
10. DFTX

Go back to 60 Degrees Pharmaceuticals enrolls first patient in tafenoquine babesiosis trial
(NASDAQ: SXTP) Delayed: 1.63 -0.01 (0.61%)
Previous Close $1.64    52 Week High $ 
Open $1.63    52 Week Low $ 
Day High $1.63    P/E N/A 
Day Low $1.63    EPS $ 
Volume 3,356       

(NASDAQ: SXTPW) Delayed: 0.04 --0 (-0%)
Previous Close $0.04    52 Week High $ 
Open $0.04    52 Week Low $ 
Day High $0.04    P/E N/A 
Day Low $0.04    EPS $ 
Volume 56